New FDA Guidance Allows Biosimilar Applicants to Use Data From Outside the U.S. To Accelerate Their Approval in the U.S.
Key Takeaway: New FDA guidance released on February 23, 2026, and March 9, 2026, signals a continued shift toward regulatory flexibility aimed at accelerating approval of biosimilar treatments for rare...
USPTO Proposes Rule and Director Implements Policy Likely to Limit Multiple Patent Validity Challenges
On Friday, October 17, the USPTO published a proposed rule that, if implemented, would likely reduce filings of inter partes review patent validity challenges. In addition, USPTO Director John Squires...
Knobbe Martens Shortlisted in Multiple Categories for 2026 Life Sciences Patent Network Awards
IRVINE, Calif., March 5, 2026 – Highlighting its strength in the life sciences industry, Knobbe Martens is pleased to share that the firm is shortlisted in multiple categories for the...
Subscribe for News and Updates
